Comparative evaluation of 11C-methionine and 18F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma
Journal of Neuro-Oncology · 2024
DOI: 10.1007/s11060-023-04534-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2024. Verfasst von Takashi Norikane und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. Hauptthemen laut MEDLINE: Glioblastoma, Lymphoma, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science.
Abstract (Originalsprache)
PURPOSE: Distinguishing between primary central nervous system lymphoma (PCNSL) and isocitrate dehydrogenase (IDH)-wildtype glioblastoma is important for therapeutic decision-making. This study aimed to compare the performance of 11C-methionine (MET) and 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for distinguishing between these two major malignant brain tumors. METHODS: We retrospectively conducted qualitative and semiquantitative analyses of pre-treatment MET and FDG PET/computed tomography (CT) images of 22 patients with PCNSL and 64 patients with IDH-wildtype glioblastoma. For semiquantitative analysis, we calculated the tumor-to-normal tissue (T/N) ratio by dividing the maximum standardized uptake value (SUV) for the tumor (T) by the average SUV for the normal tissue (N). For performance evaluation, we employed receiver operating characteristic curve analysis and calculated the areas under the curve (AUC) values. RESULTS: In the qualitative analysis, all PCNSLs and IDH-wildtype glioblastomas were MET-positive, while 95% and 84% of PCNSLs and IDH-wildtype glioblastomas, respectively, were FDG-positive. Eleven patients were excluded from the FDG PET/CT semiquantitative analysis because of hyperglycemia. There was no difference in MET T/N ratio between PCNSL and IDH-wildtype glioblastoma (p = 0.37). FDG T/N ratio was significantly higher in PCNSL than in IDH-wildtype glioblastoma (p < 0.001). The AUC value for distinguishing PCNSL from IDH-wildtype glioblastoma was significantly higher for the FDG T/N ratio (0.871) than for the MET T/N ratio (0.565) (p = 0.0027). CONCLUSION: MET PET could detect both PCNSL and IDH-wildtype glioblastoma, but unlike FDG PET, it could not distinguish between these two major malignant brain tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.
- Department of Radiology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. yamamoto.yuka@kagawa-u.ac.jp.
- Department of Neurological Surgery, Faculty of Medicine, Kagawa University, Miki-cho, Kagawa, Japan.
Förderung
- a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science
Zitieren
APA
Norikane, T., Mitamura, K., Yamamoto, Y., Manabe, Y., Murao, M., Arai-Okuda, H., Hatakeyama, T., Miyake, K., & Nishiyama, Y. (2024). Comparative evaluation of 11C-methionine and 18F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-023-04534-w
Vancouver
Norikane T, Mitamura K, Yamamoto Y, Manabe Y, Murao M, Arai-Okuda H, et al. Comparative evaluation of 11C-methionine and 18F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma. Journal of Neuro-Oncology. 2024. doi:10.1007/s11060-023-04534-w
BibTeX
@article{Norikane2024,
author = {Norikane, Takashi and Mitamura, Katsuya and Yamamoto, Yuka and Manabe, Yuri and Murao, Mitsumasa and Arai-Okuda, Hanae and Hatakeyama, Tetsuhiro and Miyake, Keisuke and Nishiyama, Yoshihiro},
title = {Comparative evaluation of 11C-methionine and 18F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma},
journal = {Journal of Neuro-Oncology},
year = {2024},
doi = {10.1007/s11060-023-04534-w}
}
EUVIMED